Activity of two phase I drugs, homoharringtonine and tricyclic nucleotide, against surgical explants of human tumors in the 6-day subrenal capsule assay. [electronic resource]
- Cancer treatment reports Feb 1983
- 173-8 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0361-5960
Acenaphthenes Alkaloids--therapeutic use Animals Dose-Response Relationship, Drug Drug Evaluation, Preclinical--methods Evaluation Studies as Topic Harringtonines--therapeutic use Homoharringtonine Humans Kidney Mice Neoplasm Transplantation Neoplasms--drug therapy Ribonucleotides--therapeutic use